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Dominant-negative inhibition of receptor-mediated endocytosis by
a dynamin-1 mutant with a defective pleckstrin homology domain
Anthony Lee*, David W. Frank†, Michael S. Marks† and Mark A. Lemmon*
The dynamins are 100 kDa GTPases involved in the
scission of endocytic vesicles from the plasma
membrane [1]. Dynamin-1 is present in solution as a
tetramer [2], and undergoes further self-assembly
following its recruitment to coated pits to form higher-
order oligomers that resemble ‘collars’ around the
necks of nascent coated buds [1,3]. GTP hydrolysis by
dynamin in these collars is thought to accompany the
‘pinching off’ of endocytic vesicles [1,4]. Dynamin
contains a pleckstrin homology (PH) domain that binds
phosphoinositides [5,6], which in turn enhance both the
GTPase activity [5,7,8] and self-assembly [9,10] of
dynamin. We recently showed that the dynamin PH
domain binds phosphoinositides only when it is
oligomeric [6]. Here, we demonstrate that interactions
between the dynamin PH domain and
phosphoinositides are important for dynamin function
in vivo. Full-length dynamin-1 containing mutations that
abolish phosphoinositide binding by its PH domain was
a dominant-negative inhibitor of receptor-mediated
endocytosis. Mutated dynamin-1 with both a defective
PH domain and impaired GTP binding and hydrolysis
also inhibited receptor-mediated endocytosis. These
findings suggest that the role of the PH domain in
dynamin function differs from that seen for other PH
domains. We propose that high-avidity binding to
phosphoinositide-rich regions of the membrane by the
multiple PH domains in a dynamin oligomer is critical
for dynamin’s ability to complete vesicle budding.
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Results and discussion
To investigate the functional role of the PH domain of
dynamin-1 (Dyn1-PH), we generated a mutated form of
full-length dynamin-1 that contains a PH domain defective
in phosphoinositide binding [6]. Although some PH
domains are independently capable of driving specific
membrane recruitment [11], others mediate only weak and
often more promiscuous interactions, requiring cooperation
with additional domains to drive membrane recruitment
[12]. Strong binding of Dyn1-PH to phosphoinositide-con-
taining membranes requires an avidity increase that can be
mimicked in vitro by inducing oligomerization of the PH
domain [6]. This finding suggested that dynamin can only
bind phosphoinositide-containing membranes, through its
PH domain, when it is oligomeric. In mammalian cells, we
have been unable to detect membrane localization of iso-
lated Dyn1-PH expressed as a fusion with green fluores-
cent protein. High-level overexpression of isolated
Dyn1-PH in HeLa cells also failed to affect receptor-medi-
ated endocytosis ([6]; data not shown), prompting us to
study the PH domain in its native context.
As shown in Figure 1, the binding of a Dyn1-PH dimer to
vesicles containing phosphatidylinositol(4,5)-bisphosphate
(PI(4,5)P2) was abolished by the site-directed mutation of
residues within the loop linking β-strands six and seven of
the PH domain (the β6–β7 loop; see legend to Figure 1)
[6]. The mutated PH domain is identical to wild type in
both its expression and secondary structure [13]. To gener-
ate a full-length form of dynamin-1 with a PH domain
defective in phosphoinositide binding (PH*-Dyn1), we
introduced the same PH-domain mutations into full-length
dynamin-1 that was tagged with a haemagglutinin (HA)
epitope at its amino terminus [14]. Using immunofluores-
cence microscopy, we compared transferrin uptake
(Figure 2a,c,e,g) by HeLa cells transiently overexpressing
wild-type dynamin-1, PH*-Dyn1, or other dynamin
mutants (cells staining positive for HA, Figure 2b,d,f,h)
with those that expressed only endogenous wild-type
dynamin (cells not staining for the HA epitope,
Figure 2b,d,f,h). The uptake of biotinylated transferrin is
evident by its detection in many small vesicles scattered
throughout the cytoplasm. Overexpression of wild-type
dynamin-1 did not detectably alter transferrin uptake
(Figure 2a,b). By contrast, cells that overexpressed PH*-Dyn1
were clearly impaired in their ability to internalize transfer-
rin (Figure 2c,d), suggesting that the PH-domain-defective
form of dynamin is a dominant-negative inhibitor of recep-
tor-mediated endocytosis. As expected [14–16], a form of
dynamin-1 containing a lysine to alanine mutation at posi-
tion 44 in the GTPase domain, Dyn1(K44A), showed a
similar dominant-negative inhibition of endocytosis
(Figure 2e,f). The presence of mutations in both the PH
and the GTPase domains (PH*-Dyn1(K44A)) did not elim-
inate the dominant-negative effect (Figure 2g,h).
Figure 2i summarizes the effects of each overexpressed
dynamin construct on transferrin uptake. Identical results
were obtained for the endocytosis of chimeric proteins
containing the well-characterized internalization signals
from Lamp1 ([17]; data not shown) or CD3γ ([18]; see 
Supplementary material published with this paper on the
internet). Thus, impairing either GTP binding and hydrol-
ysis, or phosphoinositide binding (through the PH
domain), or both, results in a form of dynamin that inhibits
receptor-mediated endocytosis in a dominant-negative
manner. This finding provides in vivo evidence of a
requirement for phosphoinositide binding by the PH
domain in dynamin function. While this manuscript was
under review, Achiriloaie et al. [19] reported that a differ-
ent mutation that abolishes PI(4,5)P2 binding by Dyn1-PH
also renders dynamin-1 a dominant-negative inhibitor of
receptor-mediated endocytosis in COS-7 cells.
Dynamin is a tetramer at micromolar-range concentrations
[2]. It further self-assembles into ring-like structures
under low-salt conditions [20] or when treated with GDP
and metallofluorides [21]. Dynamin also induces acidic
phospholipids to form membrane tubules, around which
dynamin forms helical arrays [10,22]. These assemblies,
observed in vitro, closely resemble collar-like structures
that have been seen in synaptosomes treated with non-
hydrolyzable GTP analogs [3], or around the necks of
membrane invaginations in Drosophila shibire mutants [23]
that express a mutated dynamin homolog. Concerted con-
formational changes within these collar-like structures
upon dynamin-catalyzed GTP hydrolysis are considered
to be important for the scission of endocytic vesicles from
the plasma membrane [1,4,10].
We suggest that PH*-Dyn1 exerts its dominant-negative
effect by co-oligomerizing with endogenous wild-type
dynamin and indirectly impairing its phosphoinositide
binding. Because Dyn1-PH requires oligomerization for
phosphoinositide binding [6], only oligomers of wild-type
dynamin will bind membrane phosphoinositides through
high-avidity PH-domain interactions. The inclusion of
PH-domain-defective molecules into these oligomers will
reduce this avidity effect. Given that the transiently over-
expressed dynamin constructs are more abundant than
endogenous dynamin in our experiments, all dynamin
oligomers in PH*-Dyn1-transfected cells will contain
some mutated dynamin and will therefore have impaired
phosphoinositide-binding ability. Because this results in
an inhibition of receptor-mediated endocytosis, we suggest
that the PH-domain-mediated binding of oligomeric
dynamin to phosphoinositide-containing membranes plays
a critical role in dynamin function.
One possible role for the dynamin PH domain could be to
stabilize dynamin collars around the necks of constricted
coated pits. Alternatively, once formed, these dynamin
collars could modify membrane phosphoinositide distribu-
tion at the neck through oligomeric PH-domain interac-
tions. The PH domain does not seem to be necessary for
dynamin’s initial recruitment to developing coated pits
[24], and it is not required in vitro for dynamin’s tetramer-
ization [2] or higher-order self-assembly in the absence of
membranes [2,20,21]. But, there is some evidence to
suggest that the PH domain promotes dynamin self-
assembly on acidic phospholipid membranes in vitro
[9,10]. For example, proteolytic removal of the PH domain
abolishes dynamin’s ability to form helical tubes on phos-
phatidylserine liposomes [10]. A lack of phospholipid
specificity in the promotion of dynamin self-assembly has
been interpreted as evidence against participation of the
PH domain [22]. However, although PI(4,5)P2 is the pre-
ferred binding partner of the dynamin PH domain,
oligomeric Dyn1-PH is quite promiscuous in its in vitro
phospholipid binding when compared with other PH
domains [6,8,12]. A recent study has provided evidence
that PI(4,5)P2 is required for late stages of coated vesicle
formation [25], which may reflect the participation of the
dynamin PH domain illustrated by our studies.
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Figure 1
Mutation of the β6–β7 loop of Dyn1-PH abolishes PI(4,5)P2 binding.
The β6–β7 loop of Dyn1-PH, which in human dynamin-1 has the
sequence 591TEQRNVYKDYRQ602 (in the single-letter amino-acid
code), was replaced with the analogous loop from the phospholipase
C-δ1 (PLC-δ1) PH domain (which has the sequence KDQRNT; see
[6]). The binding of dimeric forms of fusion proteins comprising
glutathione-S-transferase (GST) and either wild-type (WT) Dyn1-PH or
its β6–β7 mutant form to increasing amounts of small unilamellar
vesicles containing 3% PI(4,5)P2 in brominated phosphatidylcholine
was studied using a centrifugation assay [6]. Assuming that
approximately 50% of the PI(4,5)P2 is present on the outer surface of
the vesicles, total PI(4,5)P2 concentration values have been halved.
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It should be noted that Dyn1-PH may also interact with
other cellular components in certain endocytic processes.
Whereas isolated Dyn1-PH does not inhibit receptor-
mediated endocytosis ([6,25]; data not shown), its intro-
duction into adrenal chromaffin cells potently inhibits the
clathrin-independent process of rapid endocytosis that
follows catecholamine secretion [13]. As discussed else-
where [6,13], this effect is clearly independent of phos-
phoinositide binding by Dyn1-PH. Mutation of the β6–β7
loop does not affect the inhibition of rapid endocytosis by
Dyn1-PH, despite abolishing PI(4,5)P2 binding. By con-
trast, a mutation in the β1–β2 loop that does not alter
PI(4,5)P2 binding [6] completely prevents the ability of
Dyn1-PH to inhibit rapid endocytosis [13]. These results
suggest the presence of a non-phosphoinositide ligand for
Dyn1-PH that has yet to be identified.
Finally, the findings presented here highlight an important
difference between the role of the dynamin PH domain
and that of other PH domains studied to date. Whereas
mutations that prevent phosphoinositide binding by the
PH domains in the Btk or Akt kinases, or PLC-δ1 simply
inactivate (or impair) the function of the protein in vivo
(reviewed in [11]), mutation of dynamin’s PH domain
yields a dominant-negative inhibitor of the endogenous
protein. This difference reflects the unusual requirement
of the dynamin PH domain for oligomerization to drive its
phosphoinositide binding [6]. Similarly, whereas overex-
pression of Dyn1-PH does not affect receptor-mediated
endocytosis ([6]; data not shown), the isolated PH domains
from PLC-γ1 [26] or cytohesin-1 [27] are dominant-nega-
tive inhibitors of their respective endogenous host pro-
teins. These PH domains bind membranes independently
of their oligomeric state [12], whereas Dyn1-PH acquires
its ability to recruit dynamin to membrane phosphoinosi-
tides only when it is oligomerized through distinct
dynamin–dynamin interactions.
Materials and methods
Constructs encoding HA-tagged human dynamin-1 (wild-type and the
K44A mutant) in the tetracycline-regulatable expression vector pUHD10
were kindly supplied by Sandra L. Schmid [14]. Using the GeneEditor
kit (Promega), both forms of dynamin were mutated to alter the PH
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Figure 2
Mutation of the dynamin PH domain yields a dominant-negative inhibitor
of receptor-mediated endocytosis. tTA-HeLa cells were transiently
transfected with HA-tagged versions of the indicated dynamin
constructs, and the uptake of biotinylated transferrin was assessed
using Texas-Red-labeled streptavidin (a,c,e,g). To identify tTA-HeLa
cells expressing the HA-tagged dynamin proteins, anti-HA antibody
staining was visualized using a FITC-conjugated secondary antibody
(b,d,f,h). tTA-HeLa cells expressing only the endogenous wild-type
dynamin did not stain positively with the anti-HA antibody. (i) Semi-
quantitative representation of the results shown in (a–h). For each
construct, the percentage of transfected cells and non-transfected cells
showing uptake of labeled transferrin was determined. The mean
percentage (± standard deviation) of three experiments, each
containing more than 50 cells, is plotted for each dynamin construct.
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domain as outlined in the legend to Figure 1 (see also [6]). The different
dynamin-1 expression constructs were then transiently transfected into
tTA-HeLa cells [14] in six-well plates (2–3 µg per well) using FUGENE-
6 (Boehringer Mannheim). Cells were seeded onto coverslips 1 day
after transfection, and incubated in the absence (to induce dynamin
expression) or presence (to inhibit dynamin expression) of tetracycline
or doxycycline for 24–48 h at 37°C in 5% CO2. Endocytosis assays
were performed using Texas-Red-labeled or biotinylated transferrin.
Cells on coverslips were preincubated in DMEM containing 0.1%
bovine serum albumin for 1 h at 37°C, chilled on ice, and washed twice
with ice-cold PBS. Cells were then incubated with 25 µg/ml transferrin
for 15 min at 37°C, washed with PBS, and fixed in 2% formaldehyde (in
PBS). For immunofluorescence, fixed cells were washed and incubated
at room temperature for 1 h with 0.4 µg/ml anti-HA antibody 12CA5
(Boehringer Mannheim). Cells were then washed with PBS, and incu-
bated with FITC-labeled anti-mouse IgG alone (1.6 µg/ml) or, when
biotinylated transferrin was used, together with Texas-Red-labeled
streptavidin for 30 min at room temperature. After washing with PBS,
cells were mounted for microscopy using Fluoromount-G and viewed
using a Zeiss Axioplan fluorescence microscope.
Supplementary material
Additional methodological details and a figure showing the effects of
the different dynamin mutants on endocytosis of a chimeric protein
containing the internalization signal from CD3γ are published with this
paper on the internet.
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Supplementary materials and methods
The effects of overexpressing the dynamin-1 mutants on endocytosis
were also analyzed for a chimeric protein consisting of the extracellular
and transmembrane domains of the human Tac antigen (interleukin-2
receptor α-chain) fused to the sequence DKQTLL from the cytoplasmic
portion of CD3γ (TTγt3–t2) [S1]. The tTA-HeLa cells were grown on
12 mm coverslips in a six-well dish in DMEM containing 10% fetal
bovine serum. For each dynamin-1 variant, 1 µg mutated pUHD10 was
co-transfected with 0.2 µg pCDM8.1-Tac-DKQTLL plus 5 µg
pCDM8.1, used as carrier DNA, by calcium-phosphate-mediated trans-
fection. After 24–48 h in the absence of doxycycline (to induce dynamin
expression), cells were incubated in medium containing 50 µg/ml affin-
ity-purified anti-Tac antibody 7G7.B6 for 30 min at 37°C. Coverslips
were then immersed briefly in cold PBS, fixed, and cells immunostained
for both internalized 7G7.B6 antibody (using Texas-Red-labeled anti-
IgG2a) and expression of HA-tagged dynamin constructs (using anti-HA
antibody 16B12 (BabCo) and FITC-labeled anti-IgG1).
Reference
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Figure S1
A PH-domain-defective form of dynamin-1 inhibits internalization of a
Tac chimera containing the CD3γ internalization signal DKQTLL [S1].
Plasmids directing expression of the various dynamin-1 constructs and
the Tac–DKQTLL chimera were co-transfected into tTA-HeLa cells,
which were then allowed to express both constructs. After incubation
with the monoclonal anti-Tac antibody 7G7.B6, cells were
simultaneously stained for (a,c,e,g) endocytosis of the anti-Tac
antibody using Texas-Red labeling and (b,d,f,h) expression of the HA-
tagged dynamin-1 constructs using an anti-HA antibody and a FITC-
conjugated secondary antibody. Anti-Tac antibody internalization is
evident by the staining of small vesicles within the cell shown in (a).
Overexpression of wild-type dynamin-1 has no effect on uptake of the
anti-Tac antibody, whereas cells overexpressing PH*-Dyn1,
Dyn1(K44A), or PH*-Dyn1(K44A) — brightly stained cells in (d,f,h) —
show only surface staining for the anti-Tac antibody, indicating that
internalization of the Tac chimera has been inhibited (c,e,g).
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